Publication Date:
2022
abstract:
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly expressed on the cell surface of the microvasculature of several other solid tumors, including renal cell carcinoma (RCC). This makes it a potentially interesting imaging target for the staging and monitoring of RCC. The objective of this review is to provide an overview of the current evidence regarding the use of PSMA PET/Computed Tomography in RCC patients.
Iris type:
1.1 Articolo in rivista
Keywords:
PSMA PET/CT; imaging; kidney cancer; renal cell carcinoma
List of contributors:
Muselaers, Stijn; Erdem, Selcuk; Bertolo, Riccardo; Ingels, Alexandre; Kara, Önder; Pavan, Nicola; Roussel, Eduard; Pecoraro, Angela; Marchioni, Michele; Carbonara, Umberto; Marandino, Laura; Amparore, Daniele; Campi, Riccardo; On Behalf Of The European Association Of Urology Eau Young Academic Urologists Yau Renal Cancer Working Group, Null
Published in: